G.C. Chemie Pharmie Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 1.11 Cr
as on 18-07-2024
- Company Age 29 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 87.82 Cr
as on 18-07-2024
- Satisfied Charges ₹ 26.66 Cr
as on 18-07-2024
- Revenue -20.33%
(FY 2023)
- Profit -45.23%
(FY 2023)
- Ebitda -48.45%
(FY 2023)
- Net Worth 11.91%
(FY 2023)
- Total Assets 12.68%
(FY 2023)
About G.C. Chemie Pharmie
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.11 Cr.
The company currently has active open charges totaling ₹87.82 Cr. The company has closed loans amounting to ₹26.66 Cr, as per Ministry of Corporate Affairs (MCA) records.
Umesh Mehta, Jaydeep Mehta, Gautam Shah, and Three other members serve as directors at the Company.
- CIN/LLPIN
U51900MH1995PLC088175
- Company No.
088175
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 May 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does G.C. Chemie Pharmie Limited offer?
G.C. Chemie Pharmie Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Chemical Reagents & Catalysts, Ammonium Compound, Pharmaceutical Excipients, Non-Enteric Tablet Coating, Vitamin Powder API, Ferric Ammonium Citrate Powder API, API (Active Pharmaceutical Ingredients), Hormones and Steroid API.
Who are the key members and board of directors at G.C. Chemie Pharmie?
Executive Team (1)
GS
Gautam Shah
Managing DirectorAppointment Date: 08-May-1995
Status: Current
Board Members(5)
Financial Performance and Corporate Structure Insights of G.C. Chemie Pharmie.
G.C. Chemie Pharmie Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.33% decrease. The company also saw a substantial fall in profitability, with a 45.23% decrease in profit. The company's net worth Soared by an impressive increase of 11.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of G.C. Chemie Pharmie?
In 2023, G.C. Chemie Pharmie had a promoter holding of 99.34% and a public holding of 0.66%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
21 years 
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 02 Feb 2018 | ₹30.00 Cr | Open |
Others Creation Date: 27 Jul 2017 | ₹28.66 Cr | Open |
Icici Bank Limited Creation Date: 09 Sep 2011 | ₹3.00 Cr | Open |
How Many Employees Work at G.C. Chemie Pharmie?
G.C. Chemie Pharmie has a workforce of 74 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jan 31, 2024, G.C. Chemie Pharmie has raised a total of ₹ 8.48 M, with the most recent deal valued at ₹ 1.61 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
